Endometriosis is frequently managed with hormonal suppression that can induce hypoestrogenism during a period when many patients are still accruing peak bone mass. This narrative review summarizes current clinical and …
Endometriosis is a chronic estrogen-dependent condition affecting women of reproductive age and commonly presents with dysmenorrhea, chronic pelvic pain, dyspareunia, and infertility. In a substantial proportion of patients, pain persists …
Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen …
Endometriosis treatments and bone health Medical Republic
Endometriosis Hormonal Treatments Compromise Bone Health Medscape
Endometriosis Treatment Bone Health: A New Meta-Analysis OC Academy
To evaluate the effect of endometriosis medical therapies on bone mineral density (BMD).
Background: Uterine fibroids (UFs) and endometriosis are gynecological conditions that significantly increase morbidity among women of reproductive age. Relugolix, a novel gonadotropin-releasing hormone receptor antagonist, is approved in combined therapy …
Metatec Highlights the Link Between Endometriosis and Bone Health for Endometriosis Awareness Month EIN News